GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cronos Group Inc (TSX:CRON) » Definitions » Cyclically Adjusted PS Ratio

Cronos Group (TSX:CRON) Cyclically Adjusted PS Ratio : 22.33 (As of May. 15, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Cronos Group Cyclically Adjusted PS Ratio?

As of today (2024-05-15), Cronos Group's current share price is C$4.02. Cronos Group's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was C$0.18. Cronos Group's Cyclically Adjusted PS Ratio for today is 22.33.

The historical rank and industry rank for Cronos Group's Cyclically Adjusted PS Ratio or its related term are showing as below:

TSX:CRON' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 13.76   Med: 16.29   Max: 22.33
Current: 22

During the past years, Cronos Group's highest Cyclically Adjusted PS Ratio was 22.33. The lowest was 13.76. And the median was 16.29.

TSX:CRON's Cyclically Adjusted PS Ratio is ranked worse than
97.85% of 745 companies
in the Drug Manufacturers industry
Industry Median: 2.17 vs TSX:CRON: 22.00

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Cronos Group's adjusted revenue per share data for the three months ended in Mar. 2024 was C$0.090. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is C$0.18 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Cronos Group Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Cronos Group's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cronos Group Cyclically Adjusted PS Ratio Chart

Cronos Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 15.66

Cronos Group Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 15.85 15.66 19.43

Competitive Comparison of Cronos Group's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Cronos Group's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cronos Group's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cronos Group's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Cronos Group's Cyclically Adjusted PS Ratio falls into.



Cronos Group Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Cronos Group's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=4.02/0.18
=22.33

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cronos Group's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Cronos Group's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.09/125.4675*125.4675
=0.090

Current CPI (Mar. 2024) = 125.4675.

Cronos Group Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 0.000 99.473 0.000
201409 0.000 99.394 0.000
201412 0.000 98.367 0.000
201503 0.000 99.789 0.000
201506 0.000 100.500 0.000
201509 0.000 100.421 0.000
201512 0.000 99.947 0.000
201603 0.000 101.054 0.000
201606 0.000 102.002 0.000
201609 0.002 101.765 0.002
201612 0.003 101.449 0.004
201703 0.004 102.634 0.005
201706 0.004 103.029 0.005
201709 0.009 103.345 0.011
201712 0.010 103.345 0.012
201803 0.019 105.004 0.023
201806 0.016 105.557 0.019
201809 0.021 105.636 0.025
201812 0.032 105.399 0.038
201903 0.015 106.979 0.018
201906 0.027 107.690 0.031
201909 0.021 107.611 0.024
201912 0.026 107.769 0.030
202003 0.031 107.927 0.036
202006 0.038 108.401 0.044
202009 0.043 108.164 0.050
202012 0.061 108.559 0.071
202103 0.044 110.298 0.050
202106 0.051 111.720 0.057
202109 0.069 112.905 0.077
202112 0.054 113.774 0.060
202203 0.085 117.646 0.091
202206 0.074 120.806 0.077
202209 0.072 120.648 0.075
202212 0.079 120.964 0.082
202303 0.070 122.702 0.072
202306 0.066 124.203 0.067
202309 0.088 125.230 0.088
202312 0.084 125.468 0.084
202403 0.090 125.468 0.090

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Cronos Group  (TSX:CRON) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Cronos Group Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Cronos Group's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Cronos Group (TSX:CRON) Business Description

Traded in Other Exchanges
Address
111 Peter Street, Suite 300, Toronto, ON, CAN, M5V 2H1
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the U.S. the company has an option to acquire 10.5% of U.S. multistate operator PharmaCann upon easing of federal prohibition.